The FDA said it could not comment on the status or existence of any potential product applications.
Musk said the first two human applications targeted by the Neuralink device would be to restore vision and enable muscle movement in people who cannot do so. “Even if someone never had sight, such as if they were born blind, we believe we can still restore sight,” he said.
The event was originally scheduled for October 31, but Musk postponed it a few days earlier without giving any reason.
Neuralink’s last public presentation, more than a year ago, involved a monkey with a brain chip that played a computer game thinking alone.
Musk, who also runs electric vehicle maker Tesla, rocket firm SpaceX and social media platform Twitter, is known for lofty goals such as colonizing Mars and saving humanity. His ambitions for Neuralink, which he launched in 2016, are on the same scale.
He wants to develop a chip that would allow the brain to control complex electronic devices and eventually allow people with paralysis to regain motor function and treat brain diseases such as Parkinson’s, dementia and Alzheimer’s. He also talks about merging the brain with artificial intelligence.